{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:15:53Z","timestamp":1775690153709,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tracli.2021.07.002","type":"journal-article","created":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T11:30:22Z","timestamp":1626521422000},"page":"98-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges in management of atypical hemolytic uremic syndrome: Bottle neck in resource limited settings"],"prefix":"10.1016","volume":"29","author":[{"given":"Kshitija","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajbir","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidushi","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravneet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanvi","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paramjit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.07.002_bib0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.tracli.2021.07.002_bib0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jca.21412","article-title":"Efficacy and Safety of Therapeutic Plasma Exchange by Using Apheresis Devices in Pediatric Atypical Hemolytic Uremic Syndrome Patients","volume":"31","author":"Hans","year":"2016","journal-title":"Journal of Clinical Apheresis"},{"key":"10.1016\/j.tracli.2021.07.002_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"},{"key":"10.1016\/j.tracli.2021.07.002_bib0080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"Guidelines for the investigation and initial therapy of diarrhoea negative haemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Peditr Nephrol"},{"key":"10.1016\/j.tracli.2021.07.002_bib0085","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated haemolytic uremic syndrome in children","volume":"85","author":"Sinha","year":"2014","journal-title":"Kid Int"},{"key":"10.1016\/j.tracli.2021.07.002_bib0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1750-1172-6-60","article-title":"Atypical haemolytic uremic syndrome","volume":"6","author":"Loirat","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.tracli.2021.07.002_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical haemolytic uremic syndrome in children","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.tracli.2021.07.002_bib0100","first-page":"39","article-title":"Therapeutic Plasma Exchange: Gold standard treatment for atypical haemolytic uremic syndrome in children in India","volume":"9","author":"Chandak","year":"2019","journal-title":"IJAR"},{"key":"10.1016\/j.tracli.2021.07.002_bib0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/AJPN.AJPN_21_19","article-title":"Summary of \u2018Hemolytic Uremic Syndrome in a Developing Country: Consensus Guidelines\u2019","volume":"2","author":"Banerjee","year":"2019","journal-title":"Asian J Pediatr Nephrol"},{"key":"10.1016\/j.tracli.2021.07.002_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0971-4065.179369","article-title":"Ecluzimab for atypical hemilytic uremic syndrome in India: First report from India and the challenges faced","volume":"27","author":"Sethi","year":"2017","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.tracli.2021.07.002_bib0115","series-title":"Soliris\u00ae\u00a0Prescribing Information","year":"2020"},{"key":"10.1016\/j.tracli.2021.07.002_bib0120","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s13312-020-1920-9","article-title":"Guidelines on haemolytic uremic syndrome by Indian Society of Pediatric Nephrology: key messages","volume":"57","author":"Khandelwal","year":"2020","journal-title":"Indian Pediatr"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782021000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:55Z","timestamp":1761129535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782021000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1246782021000914"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.07.002","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in management of atypical hemolytic uremic syndrome: Bottle neck in resource limited settings","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}